Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo- and Active-Controlled, Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder

NCT00928148 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00928148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo- and Active-Controlled, Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
June 14, 2004
Completion date
November 20, 2004
Enrollment
86 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder